Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.
Last trade$66.15
Day change-$0.75 (-1.12%)
Day range$66.02 – $68.03
Volume48,000
Market cap$1.52B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$1.52B
Price / earnings
351.91×
Price / book
1.25×
Price / sales
0.6×
EV / sales
0.81×
EV / EBITDA
9.42×
Profitability
Earnings per share
$0.19
Return on assets
0.18%
Return on equity
0.35%
Dividend yield
2.36%
Liquidity and leverage
Debt / equity
0.52×
Current ratio
1.32×
Quick ratio
0.87×
Cash ratio
0.13×
Cash flow
Price / cash flow
13.27×
Price / free cash flow
333.32×
Free cash flow
$4.56M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for SCL, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$692.15M
$684.11M
$604.51M
$553.89M
$590.28M
$594.69M
$593.26M
$525.61M
Cost of revenue
$604.57M
$584.13M
$539.66M
$502.37M
$519.26M
$522.8M
$517.79M
$468.91M
Gross profit
$87.58M
$99.98M
$64.85M
$51.52M
$71.02M
$71.89M
$75.46M
$56.7M
Selling, general and administrative
$40.33M
$39.07M
$33.48M
$34.41M
$34.16M
$37.46M
$33.52M
$35.78M
Research and development
$15.67M
$17.2M
$14.99M
$15.7M
$14.23M
$14.7M
$14.65M
$13.79M
Total operating expenses
$61.62M
$62.77M
$114.47M
$56.91M
$49.23M
$53.92M
$47.18M
$49M
Operating income
$25.96M
$37.21M
-$49.62M
-$5.39M
$21.79M
$17.97M
$28.29M
$7.7M
Interest expense
-$6.34M
-$5.68M
-$5.01M
-$5.69M
-$6.82M
-$5.49M
-$4.13M
-$4.83M
Income before taxes
$19.83M
$32.55M
-$54.49M
$4.94M
$16.52M
$13.79M
$24.66M
$2.46M
Income taxes
$2.01M
$9.64M
-$13.08M
-$65K
$5.68M
$2.45M
$4.95M
-$894K
Net income
$17.81M
$22.91M
-$41.41M
$5M
$10.84M
$11.34M
$19.71M
$3.35M
Net income attributable to common shareholders
$17.81M
$22.91M
-$41.41M
$5M
$10.84M
$11.34M
$19.71M
$3.35M
EBITDA
$62.83M
$73.24M
$48.76M
$33.59M
$54.54M
$49.25M
$57.56M
$36.22M
Basic earnings per share
$0.78
$1.00
-$1.81
$0.22
$0.47
$0.50
$0.86
$0.15
Diluted earnings per share
$0.78
$1.00
-$1.81
$0.22
$0.47
$0.50
$0.86
$0.15
Recent news
Company coverage with links to the original publishers.
Stepan reported an 18% increase in adjusted EBITDA to $66 million in Q3 2026, driven by 7% organic sales volume growth across all segments and market share gains. The company leveraged contractual pass-through clauses to protect margins against rising raw material costs, while its Project Catalyst restructuring program delivered $23 million in run-rate savings. Net debt leverage improved to 2.4 times earnings, with management projecting continued EBITDA growth and positive free cash flow for full-year 2026.
Avient (AVNT) has significantly outperformed the Basic Materials sector year-to-date, gaining 30.5% compared to the sector average of 11.5%. The stock holds a Zacks Rank #1 (Strong Buy) with improving analyst sentiment, as consensus earnings estimates have increased 3.9% over the past 90 days. Stepan Co. (SCL) is another strong performer in the same Chemical - Diversified industry, returning 31.3% year-to-date.
Zacks highlights two stocks with Strong Buy ratings and positive momentum: Stepan Company (SCL), a specialty chemicals manufacturer with a 10.3% earnings estimate increase over 60 days and 12.3% three-month gains; and AC Immune (ACIU), a biopharmaceutical company focused on neurodegenerative diseases with a 28.6% earnings estimate increase and 9.2% three-month gains.
Five companies have been added to the Zacks Rank #1 (Strong Buy) list based on increasing consensus earnings estimates over the last 60 days. The stocks include Motorsport Games (30.4% earnings estimate increase), Gray Media (24.9% increase), Helios Technologies (10% increase), Embraer (8.1% increase), and Stepan Company (5.9% increase).
The global alpha olefin sulfonate (AOS) market is projected to grow from USD 722.3 million in 2025 to USD 942.6 million by 2030, with a CAGR of 5.47%. Growth is driven by increasing demand for industrial and institutional cleaning applications, with liquid and paste segments showing the highest growth potential. Key market drivers include the shift towards sulfate-free cleaning systems and expansion in industrial cleaning sectors, while challenges include volatility in feedstock prices and competition from bio-based alternatives.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
Declared upcoming dividend$0.405 per share
Declared
Oct 27, 2026
Ex-dividend
Dec 1, 2026
Pay date
Dec 15, 2026
Ex-dividend
Amount / share
Pay date
Type
Sep 1, 2026
$0.395
Sep 15, 2026
recurring
Jun 1, 2026
$0.395
Jun 15, 2026
recurring
Mar 2, 2026
$0.395
Mar 13, 2026
recurring
Nov 28, 2025
$0.395
Dec 15, 2025
recurring
Aug 29, 2025
$0.385
Sep 15, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.